[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fBI6X4c-WaIrHDD_aIMM1f9iXE5t7ZPAdvdKGu7g8_zc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":40,"rows":47},"San Diego State University",[4],142,false,49,0,106252,1,140,[14,17,20,22,24,26,29,31],{"name":15,"count":16},"Depression",6,{"name":18,"count":19},"Cardiovascular Diseases",5,{"name":21,"count":19},"Satiety",{"name":23,"count":19},"Postprandial Hyperglycemia",{"name":25,"count":19},"Obesity",{"name":27,"count":28},"Lung Diseases",4,{"name":30,"count":28},"Healthy",{"name":32,"count":33},"Asthma",3,[35],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT05007561","Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences","2027-04","Naltrexone Hydrochloride",[41,42,43,44,45,46],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[48,72],{"intervention":39,"totalTrials":11,"cells":49},{"EARLY_PHASE1":50,"PHASE1":62,"PHASE2":64,"PHASE3":66,"PHASE4":68,"NA":70},{"trials":51,"activeCount":11,"soonestReadout":38},[52],{"nctId":36,"briefTitle":37,"status":53,"phases":54,"primaryCompletion":38,"completion":55,"start":56,"enrollment":57,"conditions":58,"interventions":61},"RECRUITING",[41],"2027-07","2021-11-16",210,[59,60],"Naltrexone","Placebo",[39],{"trials":63,"activeCount":9},[],{"trials":65,"activeCount":9},[],{"trials":67,"activeCount":9},[],{"trials":69,"activeCount":9},[],{"trials":71,"activeCount":9},[],{"intervention":73,"totalTrials":11,"cells":74},"Lidocaine",{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":85},{"trials":76,"activeCount":9},[],{"trials":78,"activeCount":9},[],{"trials":80,"activeCount":9},[],{"trials":82,"activeCount":9},[],{"trials":84,"activeCount":9},[],{"trials":86,"activeCount":9},[87],{"nctId":88,"briefTitle":89,"status":90,"phases":91,"primaryCompletion":92,"completion":92,"start":93,"enrollment":94,"conditions":95,"interventions":97},"NCT05379283","Does Topical Lidocaine Decrease Sweat During Exercise in the Heat?","COMPLETED",[46],"2022-09-15","2022-05-15",10,[96],"Sweat Pore Closure",[73]]